Barbeta Enric, Ferrando Carlos, López-Aladid Rubén, Motos Anna, Bueno-Freire Letícia, Fernández-Barat Laia, Soler-Comas Alba, Palomeque Andrea, Gabarrús Albert, Artigas Antonio, Camprubí-Rimblas Marta, Li Bassi Gianluigi, López-Sobrino Teresa, Sandoval Elena, Toapanta David, Fernández Sara, Mellado-Artigas Ricard, Zattera Luigi, Vallverdú Jordi, Laffey John G, Ferrer Miquel, Torres Antoni
Surgical Intensive Care Unit, Hospital Clínic de Barcelona, Barcelona, Spain; CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain; Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain; University of Barcelona (UB), Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain; University of Barcelona (UB), Barcelona, Spain.
Anaesth Crit Care Pain Med. 2025 Jan;44(1):101458. doi: 10.1016/j.accpm.2024.101458. Epub 2024 Dec 20.
Driving pressure is thought to determine the effect of low tidal ventilation on survival in patients with acute respiratory distress syndrome. The leading cause of mortality in these patients is non-pulmonary multiorgan dysfunction, which is believed to worsen due to the biological response to mechanical ventilation (biotrauma). Therefore, we aimed to analyze the association between driving pressure, biotrauma, and non-pulmonary multiorgan dysfunction. Additionally, we analyzed this relationship for tidal volume/predicted body weight.
Observational study that included adult patients with acute respiratory distress syndrome undergoing invasive mechanical ventilation admitted to the Hospital Clinic of Barcelona, Spain, between June 2019 and February 2021. We conducted mixed-effects models to assess the effects of driving pressure and tidal volume/predicted body weight on the evolution of 22 log-transformed biomarker variables during the first, third, and fifth days after study enrollment. These 22 systemic biomarkers characterized epithelial and endothelial pulmonary dysfunction, inflammation, and coagulation disorders in the included patients. In the same fashion, the association between driving pressure and non-pulmonary multiorgan dysfunction was evaluated by the non-pulmonary sequential organ failure assessment score (non-pulmonary SOFA) and its associated variables. Finally, we performed mediation analyses to assess whether the relationship between biomarkers and driving pressure was mediated by other ventilator-induced lung injury parameters.
Thirty-eight patients were included. Driving pressure was independently associated with soluble Receptor for advanced glycation end-products, Interleukin (IL)-8, IL-6, IL-10, IL-17, Interferon-ɣ, Chemokine (C-C motif)-2, Vascular endothelial growth factor, Tissue factor, Protein C, Protein S, and higher dose of norepinephrine. However, this relationship attenuated over time. In contrast, tidal volume/predicted body weight was not associated with any of the 22 biomarkers tested . A concomitant increase in positive end-inspiratory plateau pressure or tidal volume did not mediate the effect of driving pressure on biomarkers. Conversely, the association between compliance of the respiratory system and pulmonary epithelial dysfunction was primarily mediated by driving pressure.
Driving pressure, but not tidal volume/predicted body weight, was correlated with epithelial and endothelial pulmonary dysfunction, inflammation, coagulation disorders, and hemodynamic dysfunction. However, this relationship diminished over time.
驱动压被认为决定了低潮气量通气对急性呼吸窘迫综合征患者生存的影响。这些患者的主要死亡原因是非肺部多器官功能障碍,据信这种情况会因对机械通气的生物学反应(生物创伤)而恶化。因此,我们旨在分析驱动压、生物创伤和非肺部多器官功能障碍之间的关联。此外,我们还分析了潮气量/预测体重与上述因素的关系。
这是一项观察性研究,纳入了2019年6月至2021年2月期间在西班牙巴塞罗那医院诊所接受有创机械通气的成年急性呼吸窘迫综合征患者。我们采用混合效应模型来评估驱动压和潮气量/预测体重对入组后第1天、第3天和第5天22个经对数转换的生物标志物变量变化的影响。这22个全身生物标志物表征了纳入患者的上皮和内皮肺功能障碍、炎症及凝血紊乱情况。同样,通过非肺部序贯器官衰竭评估评分(非肺部SOFA)及其相关变量来评估驱动压与非肺部多器官功能障碍之间的关联。最后,我们进行中介分析,以评估生物标志物与驱动压之间的关系是否由其他呼吸机诱导的肺损伤参数介导。
共纳入38例患者。驱动压与晚期糖基化终产物可溶性受体、白细胞介素(IL)-8、IL-6、IL-10、IL-17、干扰素-γ、趋化因子(C-C基序)-2、血管内皮生长因子、组织因子、蛋白C、蛋白S以及更高剂量的去甲肾上腺素独立相关。然而,这种关系会随时间减弱。相比之下,潮气量/预测体重与所检测的22种生物标志物均无关联。吸气末平台压或潮气量的同时增加并未介导驱动压对生物标志物的影响。相反,呼吸系统顺应性与肺上皮功能障碍之间的关联主要由驱动压介导。
驱动压而非潮气量/预测体重与肺上皮和内皮功能障碍、炎症、凝血紊乱及血流动力学功能障碍相关。然而,这种关系会随时间减弱。